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Recent studies have indicated that the serotonin receptor subtype 7 (5-HT7R)
plays a crucial role in shaping neuronal morphology during embryonic and early
postnatal life. Here we show that pharmacological stimulation of 5-HT7R using a
highly selective agonist, LP-211, enhances neurite outgrowth in neuronal primary
cultures from the cortex, hippocampus and striatal complex of embryonic mouse brain,
through multiple signal transduction pathways. All these signaling systems, involving
mTOR, the Rho GTPase Cdc42, Cdk5, and ERK, are known to converge on the
reorganization of cytoskeletal proteins that subserve neurite outgrowth. Indeed, our
data indicate that neurite elongation stimulated by 5-HT7R is modulated by drugs
affecting actin polymerization. In addition, we show, by 2D Western blot analyses,
that treatment of neuronal cultures with LP-211 alters the expression profile of cofilin,
an actin binding protein involved in microfilaments dynamics. Furthermore, by using
microfluidic chambers that physically separate axons from the soma and dendrites, we
demonstrate that agonist-dependent activation of 5-HT7R stimulates axonal elongation.
Our results identify for the first time several signal transduction pathways, activated
by stimulation of 5-HT7R, that converge to promote cytoskeleton reorganization and
consequent modulation of axonal elongation. Therefore, the activation of 5-HT7R might
represent one of the key elements regulating CNS connectivity and plasticity during
development.
Keywords: 5-HT7 receptor, actin dynamics, axonal elongation, Cdc42, mTOR, neurite outgrowth
Abbreviations: 5-HT, 5-hydroxytryptamine; 5-HT7R, serotonin receptor 7; Cdc42, cell division cycle 42; Cdk5, cyclin-
dependent kinase 5; CTX, cortex; E, embryonic age; ERK, extracellular signal-regulated kinases 1/2; HIPP, hippocampus;
mTOR, mammalian target of rapamycin; p70S6K, p70 S6 kinase; STR, striatal complex.
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Introduction
The neurotransmitter serotonin (5-hydroxytryptamine, 5-HT)
modulates a variety of physiological processes in the Central Ner-
vous System (CNS). In addition to its well-established role in
neurotransmission, 5-HT has been shown to regulate the connec-
tivity of the brain by modulating cellular migration and cytoar-
chitecture during development (Daubert and Condron, 2010).
Mammalian brain contains extensive serotonergic projections
that exert their effects through at least 14 different subtypes
of 5-HT receptors, classified into 7 different families (Pytliak
et al., 2011). The 5-HT receptor 7 (5-HT7R) is the most recently
identified 5-HT receptor. This seven-transmembrane G-protein-
coupled receptor is positively linked to adenylate cyclase through
the stimulatory Gs protein and Gα-12 subunit of heterotrimeric
G-protein (Kvachnina et al., 2005; Leopoldo et al., 2011), and
it is expressed in CNS and periphery. In human and rodent
CNS, high densities of 5-HT7R have been found in hypotha-
lamus, thalamus, hippocampus, cortex, amygdala and striatal
complex. This distribution is highly correlated with 5-HT7R
functions in the CNS, namely circadian rhythm, REM sleep, ther-
moregulation, learning and memory and nociception (Matthys
et al., 2011; Adriani et al., 2012). Consistent with such a broad
range of functions, its deregulation has been associated with
numerous pathological processes of the CNS, such as obsessive—
compulsive disorder (OCD), anxiety, schizophrenia, epilepsy,
migraine, sensation-seeking behavior, impulsivity and depression
(Cates et al., 2013; Gellynck et al., 2013).
Although precise biological roles 5-HT7R are not well known
yet, recent studies suggest that this receptor might be impli-
cated in the modulation of synaptic wiring in the CNS. Interest-
ingly, 5-HT7R expression was markedly increased in adolescent
rodents administered with methylphenidate. These animals dis-
play specific changes in brain reward circuits and in the reward-
based behavior, suggesting that 5-HT7R may play a major role in
the modulation of self-control behavior by supporting the per-
sistent brain structural rearrangements during postnatal devel-
opment (Adriani et al., 2006; Leo et al., 2009). Indeed, it has
been shown that 5-HT7Rmodulates hippocampal neuronal mor-
phology, excitability and plasticity, by participating in dendritic
morphogenesis and synaptogenesis (Kobe et al., 2012; Tajiri et al.,
2012). In line with these results, pharmacological stimulation of
5-HT7R with a new selective agonist, LP-211 (Hedlund et al.,
2010), has been successfully employed to rescue the synaptic
plasticity deficits in hippocampal slices from a mouse model of
the X-fragile syndrome (Costa et al., 2012) and to alleviate the
behavioral phenotype in a mouse model of the Rett syndrome
(De Filippis et al., 2014). Thus, all these recent findings indicate
that 5-HT7R controls neuritogenesis and synaptogenesis, but the
signaling mechanisms remain poorly understood.
Recently we have shown that 5-HT7R activation in neuronal
primary cultures from rat brain stimulates neurite outgrowth
through Cdk5 and extracellular signal-regulated kinases 1/2
(ERK) pathways, with the modifications of selected cytoskeletal
proteins (Speranza et al., 2013), supporting the hypothesis
that the 5-HT7R might play a crucial role in shaping neu-
ronal networks during development (Volpicelli et al., 2014).
The modulation of connectivity in the nervous system requires
remodeling of neuronal morphology and synaptic connections,
which in turn depend on dynamic reorganization of cytoskeleton.
Various extracellular cues induce changes of the actin cytoskele-
ton to remodel the structure and the function of subcellular
regions by way of numerous signaling pathways, and dynamic
changes of actin filaments are crucial for neurite outgrowth and
axonal pathfinding and synaptogenesis (Schaefer et al., 2008).
One of the most characterized actin-binding proteins, cofilin,
binds, twists and severs actin filaments enabling remodeling of
the actin cytoskeleton (Bernstein and Bamburg, 2010; Bravo-
Cordero et al., 2013). Cofilin is regulated by the upstream signal-
ing pathways involving Rho/Rac/Cdc42 GTPase; in turn, the Rho
signaling pathway and the consequent cofilin-dependent actin
polymerization are, in many cells, under the control of the mam-
malian target of rapamycin (mTOR; Jaffe andHall, 2005; He et al.,
2013). The latter is a multifunctional serine/threonine protein
kinase which also plays important roles in neurite elongation,
dendritic spines shape and synaptogenesis (Guo et al., 2011; Briz
and Baudry, 2014; Takei and Nawa, 2014).
In this work we have first demonstrated that the stimulation of
5-HT7R with the selective agonist LP-211 (Hedlund et al., 2010)
leads to enhanced neurite outgrowth in embryonic neuronal
primary cultures derived from the cortex (CTX), hippocampus
(HIPP) and striatal complex (STR) of embryonic mouse brain
corroborating the results that we have previously obtained in
rat brain (Speranza et al., 2013). As an extension of this find-
ing, we have herein analyzed several intracellular transduction
pathways connecting the stimulation of 5-HT7R to neurite elon-
gation. We have found that, in addition to ERK phosphoryla-
tion and Cdk5 activation, mTOR and Cdc42 are activated during
the 5-HT7R-dependent neurite elongation. With all these path-
ways converging in the modulation of the dynamics of neuronal
cytoskeleton proteins, our data indicate that signals activating
5-HT7R is transduced to neurite elongation via remodeling of
actin cytoskeleton. In addition, by use of the microfluidic cham-
bers, we have demonstrated for the first time that the neurites
outgrowing in response to 5-HT7R stimulation include axons,
suggesting an unexpected role of this receptor in axonal pathfind-
ing and regeneration.
Materials and Methods
Neuronal Primary Cultures
Timed pregnant C57 BL/6 mice were housed, cared for and
sacrificed in accordance with the recommendations of the Euro-
pean Commission. All the procedures related to animal treat-
ments were approved by Ethic-Scientific Committee for Animal
Experiments and Italian Health Ministry. The embryonic age (E)
was determined by the date of insemination (i.e., the appearance
of vaginal plug was considered as day E0). For every cell cul-
ture preparation, about 15–20 embryos from different dams were
pooled. The STR and CTX from E15 embryos, and the HIPP
from E18 embryos were dissected under a stereoscope in ster-
ile conditions, and placed in PBS without calcium and magne-
sium, supplemented with 33mM glucose. Cells dissociated from
embryonic STR, CTX, and HIPP were cultured as previously
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described (di Porzio et al., 1980). Briefly, the dissected areas
were enzymatically dissociated by incubation for 30min at 37◦C
in a papain solution (Warthington, 20 U/ml, Milan, Italy) in
Earle’s balance salts containing 1mM EDTA (Sigma-Aldrich,
Milan, Italy), 1mM cysteine (Sigma-Aldrich) and 0.01% pan-
creatic DNAse (Sigma-Aldrich). After addition of 1mg/ml of
bovine serum albumin (Sigma-Aldrich) and 1mg/ml ovomucoid
(Sigma-Aldrich) the cells suspensions were centrifuged 5min at
800 × g, resuspended in plating medium and counted (Fiszman
et al., 1991). For the viable cell count, cell suspension was diluted
1:1 with 0.1% trypan blue dye (Sigma-Aldrich) and loaded into
a disposable cell counting chamber-slide. Cell concentration was
determined on the basis of the total cell count, the dilution factor
and the trypan blue dye exclusion.
Dissociated cells were plated at a density of 1.5 × 105/cm2 in
2 cm2 Lab-Tek chamber slides (Nunc) for morphological analy-
ses, and at a density of 3× 105/cm2 in 9,5 cm2 cell culture dishes
(Corning) for RNA purification and Western blot analyses. Both
chamber slides and cell culture dishes were coated with 15µg/ml
of poly-D-Lysine dissolved in water (Sigma-Aldrich).
Cultures were grown in serum-free Neurobasal medium
(Life technologies, Milan, Italy), supplemented with B27 (Life
technologies), 2mM L-glutamine (Sigma-Aldrich), penicillin
(50U/ml, Sigma-Aldrich) and streptomycin (50µg/ml, Sigma-
Aldrich). Cells were maintained for 3 days in vitro (DIV) at 37◦C
in a humidified incubator in presence of 5% CO2, before experi-
mental manipulation. For each experimental point, cultures were
prepared at least in independent triplicates, and were repeated
using distinct culturing sessions.
Drugs and Reagents
The cell cultures were treated with 100 nM of the selective
5-HT7R agonist LP-211 (gift of M. Leopoldo, University of Bari,
Italy), 100 nM of the HT7R antagonist SB-269970 (Tocris, Milan,
Italy; Hagan et al., 2000), or with a combination of these drugs.
Roscovitine (Sigma-Aldrich), a Cdk5 inhibitor, was used at the
final concentration of 20µM. The mTOR inhibitors rapamycin
(Sigma-Aldrich) and torin 1 (Tocris), were used at a final con-
centration of 20 and 250 nM, respectively. ZCL 278 (Tocris), a
selective inhibitor of Cdc42, was used at a final concentration
of 50µM. Cytochalasin D (Sigma -Aldrich) was used at a final
concentration of 100 nM, while latrunculin and jasplakinolide
(Molecular Probes, Milan, Italy) were used at a final concentra-
tion of 2µM. Cells were pretreated for 30min with 10µM of
U0126, the ERK 1/2 inhibitor, as recommended by manufacturer
(Cell Signaling, Milan, Italy). Drugs were added to cultures 72 h
after cell plating and incubated for appropriate time.
RNA Isolation and RT-PCR Analyses
Total RNA was extracted from primary cells cultured in 4 cm2
wells, 3 days after seeding, using the Tri-Reagent according to
the manufacturer’s instructions (Sigma-Aldrich). The analyses
were always carried out in triplicate samples for each experimen-
tal point. Reverse transcriptase and quantitative real time PCR
analyses were performed as described in Speranza et al. (2013).
Primer sets used were:
5-HT7R: Fw GCGGTCATGCCTTTCGTTAGT—Rev GGC-
GATGAAGACGTTGCAG;
HPRT: Fw TGGGAGGCCATCACATTGT—Rev
AATCCAGCAGGTCAGCAAAGA.
Gene expression levels were quantified by the comparative
threshold cycle (CT) method (Schmittgen and Livak, 2008) using
hypoxanthine phosphoribosyltransferase (HPRT) as an internal
control gene. The fractional number of PCR cycles (CT) required
to obtain a given amount of amplified product in the exponential
phase of amplification was determined for the gene of interest
and for HPRT in each cDNA sample. The relative expression
level of the gene of interest was then expressed as 2 −!CT where
!CT = CT gene of interest—CT HPRT.
Morphological Characterization and Analysis of
Morphometric Parameters
For morphological characterization of neuronal cultures, cells
were fixed in 4% paraformaldehyde in phosphate buffered saline
(PBS), for 30min at room temperature (RT), washed three times
in PBS, and then permeabilized for 20min in PBS containing
0.1% Triton-X-100 and 10% normal goat serum (NGS). Cells
were treated with blocking solution [10% NGS, 0, 1% bovine
serum albumine (BSA) in PBS] at RT for 1 h and incubated
with the primary antibody in antibody solution (0, 1% BSA in
PBS) overnight at 4◦C. The following antibodies were used at the
indicated dilutions: monoclonal antibody against neuron specific
class III β-tubulin (Tuj1, Covance, Milan, Italy) 1:500 and poly-
clonal antibody 5-HT7 receptor (Imgenex, Milan, Italy) 1:70. The
cells were washed in PBS, and then incubated with fluorescent
secondary antibodies (Alexa Fluor goat anti-rabbit, and Alexa
Fluor Goat goat anti-mouse, Life technologies) diluted 1:400 in
antibody solution.
Cells were then counterstained with DAPI (nuclear stain,
1:1000) for 10min, washed with PBS and mounted with oil
mounting solution (Mowiol). Fluorescent signals from Tuj1
stained neurons were detected with a microscope (Leica
DM6000B) equipped with an objective 20x. Images were acquired
with high-resolution camera using the software Leica Application
Suite, and were analyzed by the image-processing software Image
J, for the perimeter and the area of the soma, neurites number
and length. In each image, the neuronal cells were recognized by
their immunoreactivity with Tuj1 antibody. Using the Image J
software the images were pre-processed to optimize illumination
and contrast. The length of the neurites was estimated by mea-
suring the length of a line manually drawn from the soma to the
end of the primary neurites (neurites that originate directly from
soma) using the “Measure” function of the software (modified
from Hannan et al., 2014; Figure 2A).
Only clearly visible cells were subjected to analysis to pre-
vent inaccurate scoring. A total of 15 fields for each cell-culture
condition was selected from at least three independently treated
culture wells. A total of 300 neurites/well was traced from Tuj1
positive neurons to measure their length. The analyses were car-
ried out blindly to avoid any subjective influences during the
measurements.
Morphometric parameters were always compared to the con-
trols from the same batch of dissociated cells treated with vehicle
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alone for the same time length (CTRL). Significant agonist-
induced increase in neurite length varied always between 1.2
and 2 fold compared to CTRL. For easy comparison of the
results among various cell preparations, data were expressed as
percentage of the average CTRL.
Incubation and Immunofluorescence in
Microfluidic Chambers
Hippocampal neuron cultures were prepared from 18-day old
(E18) mouse embryos. The hyppocampi were dissected in cold
HBSS 1X and 3mM HEPES (Life Technologies), containing
antibiotics (100 unit/ml penicillin and 0.1mg/ml streptomycin,
Sigma-Aldrich), and transferred into a 15ml tube. After a rinse
in buffer, specimens were incubated, for 30min at 37◦C, with
40µl/HIPP of 0.5% trypsin (EuroClone SpA, Pero, Italy) (equiv-
alent to 0.2mg trypsin/HIPP) and 100µg/ml DNAase. After an
extensive wash, hippocampi were mechanically dissociated and
cell density was determined using a counting chamber. Cells were
re-suspended in 100µl of the appropriate medium and plated
in microfluidic chambers (Xona Microfluidics LLC, Temecula,
California USA; Taylor et al., 2005; Park et al., 2006). Cham-
bers were prepared as suggested by manufacturer’s instructions:
briefly, 35mm Petri dishes were coated overnight with 100µg/ml
poly-L-lysine (Sigma-Aldrich) at 37◦C and then washed and air
dried under a sterile hood. Poly-dimethylsiloxane chambers were
placed on the Petri dishes with their micro-channel side down,
sealed to the dish by gentle pressure and filled with 20µg/ml
laminin (Sigma-Aldrich), for 2 h at 37◦C. Laminin was removed
just before plating cells, approximately 100,000 cells were pipet-
ted directly into one compartment (the soma compartment) and
then both compartments were filled with Neurobasal medium
containing 1X B27 supplement (Life Technologies), 0.5mM glu-
tamine, 25µM glutamate and antibiotics. When neurons were
plated at this density, very few cells approached the micro-
channels, so that most likely one axon/channel enters. Cells were
exposed to DMSO (control) or DMSO + LP-211, added to both
compartments (somatic and axonal), and maintained in vitro for
6 days (6DIV). Medium was changed every 24 h and the number
of axons reaching the axonal compartment was blindly counted
every day by three operators, from 1 to 6DIV, at the inverted
microscope, in phase contrast, at a magnification of 40x. Finally,
at 6DIV, after the last count, cells were fixed in 4% formaline and
4% sucrose in PBS for 30min at RT, added directly to both com-
partments, without removing the microfluidic chambers. After
fixation, cells were blocked in 1% BSA (Sigma-Aldrich), 10%
normal goat serum (NGS) (Jackson ImmunoResearch Europe
Ltd, Suffolk, England) and 0.5% Triton X-100 in PBS, for 1 h
at RT, and then incubated overnight at 4◦C with the primary
antibodies diluted in 1% bovine serum albumin, 1% NGS and
0.2% Triton X-100 in PBS. Antibodies used were: mouse anti-
neuron specific βIII-tubulin (Tuj1; Covance, Emeryville, CA,
USA, #MMS-435P; 1:3000), in co-localization with either rabbit
anti Map2 (AbCam, Cambridge, UK, #32454; 1:400), to visualize
dendrites, or rabbit anti Tau (AbCam, #ab64193; 1:50), to visual-
ize axons. Cells were then incubated for 1 h at RT with the appro-
priate secondary antibodies: goat anti-mouse IgG Alexa Fluor
488 (Molecular Probes, Life Technologies) and goat anti-rabbit
IgG Cy3 (Jackson ImmunoResearch), both diluted 1:1000. Pro-
Long Gold Antifade Reagent (Invitrogen, Life Technologies) was
added to both compartments to visualize and store immunolabed
cells.
Gel Electrophoresis and Western Blot Analyses
For mono-dimensional polyacrylamide gel electrophoresis
(PAGE), culture dishes were lysed in RIPA Buffer in pres-
ence of protease inhibitors (Roche, Milan, Italy). Proteins
(15–30µg/lane) were separated on 10–12% SDS-polyacrilamide
gel and transferred to PVDF membranes (GE Healthcare,
Milan, Italy). For experiments with S6 kinase, Akt and cofilin
antibodies, culture dishes were lysed in 20mM MOPS pH 7,
2mM EGTA, 5mM EDTA, 30mM NaF, 60mM β-glycerol-
phosphate, 1µM sodium orthovanadate, 1% triton), in presence
of protease inhibitors. Proteins (20–30µg/lane) were separated
as previously described and transferred to PVDF membranes.
Filters were blocked for 30min in 5% (w/v) non-fat milk in
Tris-buffered saline Tween-20 (TBST; 0.1% Tween, 150mM
NaCl, 10mM Tris-HCl, pH 7.5) and probed for 2 h at RT
with the following antibodies: anti-5-HT7 receptor (Imgenex
IMG-368, 1:300), anti-β-actin (BD Transduction Laborato-
ries, #612656, 1:1000), anti-p-ERK1/2 (Cell Signaling, #9101,
1:750), anti-ERK 1/2 (Santa Cruz Biotechnology # sc-93,
Milan, Italy1:1000), p70 S6 kinase (Cell Signaling, #2708,
1:1000), phospho-p70 S6 kinase (Thr389; Cell Signaling, #9234,
1:1000), Akt (Cell Signaling, #9272, 1:1000), phospho-Akt
(Ser473; Cell Signaling, #4060, 1:1000), cofilin (Cell Signaling,
#5175, 1:1000) and p-cofilin (phospho Ser3; Abcam, ab12866,
1:1000). After washing, immunoblots were incubated with goat
anti-rabbit IgG (GE Healthcare ECL, 1:10000) or anti-mouse
IgG antibodies (GE Healthcare ECL, 1:10000) conjugated to
horseradish peroxidase (HRP) and visualized on autoradio-
graphic film, using enzyme-linked chemiluminescence (ECL;
Immobilion Western, Millipore). The relative protein levels
were determined by densitometry and compared with the
protein level of the appropriate standard (β-actin for 5-HT7R
blots, p70 S6 kinase for phospho-p70 S6 kinase blots, cofilin
for p-cofilin blots, and ERK1/2 for p-ERK1/2 blots) probed
on the same membrane, after stripping of the antibody pre-
viously used. Net intensity value of each band was calculated
by subtracting the background of each area from the total
intensity.
For 2D-PAGE, monolayer cultures of striatal and cortical cells,
treated or untreated with LP-211, were harvested, washed three
times with PBS and lysed in the lysis buffer (40mM Tris-HCl pH
8.0, 8M urea, 4% CHAPS, 65mM DTT, and 1mM PMSF). Pro-
teins were extracted by repeated freezing and thawing with liquid
nitrogen and pooled from 3 independent culture dishes. Samples
were centrifuged at 17500 g for 15min at 4◦C to eliminate cellular
debris and sonicated into an ultrasonic bath for 15min. Sam-
ples were then centrifuged at 17500 × g for 15min at 4◦C. The
supernatant was collected and protein concentration determined
by the Bradford method, according to manufacturer’s instruc-
tions (Bio-Rad, Milan, Italy). Lysates were aliquoted and stored
at −80◦C until use. 50µg of lysate proteins were analyzed by
2D-PAGE, as previously described (Speranza et al., 2013). Briefly,
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 March 2015 | Volume 9 | Article 62
Speranza et al. 5-HT7R, mTOR and neurite elongation
samples to be processed by isoelectrofocusing (IEF) were diluted
with the rehydration buffer (8M urea, 0.5% CHAPS, 0.2% DTT,
0.5% IPG ampholytes, and 0.002% bromophenol blue) to a final
volume of 125µl. The precast IPG strips (3–10 linear pH gradi-
ent, 7 cm long, GE Healthcare), used for the first dimension, were
passively rehydrated and loaded with the sample at RT for 12 h
under low-viscosity paraffin oil. IEF was then performed using
an IPGphor isoelectric focusing cell (GE Healthcare), according
to the following protocol: 50V for 3 h, 100V for 2 h, 500V for
2 h, 1000V for 2 h, 3000V for 2 h, 4000V for 2 h, 5000V for
2 h, 6000V for 2 h, 8000V until about 25000V h total. Strips
were then equilibrated twice for 15min under gentle shaking in
the equilibration solution (6M urea, 50mM Tris-HCl buffer pH
8.8, 30% glycerol, 2% SDS, 0.002% bromophenol blue) contain-
ing 1% DTT (to reduce disulfide bonds), in the first equilibration
step, and 2.5% iodoacetamide (to alkylate thiols), in the sec-
ond step. The second-dimension separation was performed on
12% polyacrylamide gels (0.75mm × 7.5 × 10 cm) by using a
Miniprotean II apparatus. The strips were fixedwith 0.5% agarose
and 0.002% bromophenol blue dissolved in SDS/Tris running
buffer. The run was carried out at constant power (10mA/gel
for 15min; 20mA/gel until the end of the run). After the second
dimension, 2D-gels were electroblotted onto nitrocellulose mem-
branes by using a TransBlot Turbo system (Bio-Rad) following
themanufacturer’s instructions. Themembrane was blocked with
5% milk in TBS-0.1% Tween (TTBS) for 1 h at RT and washed
with TTBS. Subsequently, membranes were incubated with pri-
mary antibodies diluted in 2.5% milk in TTBS overnight at 4◦C.
The following antibodies were used: anti-β-actin (BD Transduc-
tion Laboratories, #612656, 1:5000); anti-cofilin (Cell Signaling,
#5175, 1:1000); β-tubulin (Covance, MMS-435P, 1:1000). Mem-
branes were then washed with TTBS and incubated with the
appropriate HRP-conjugated secondary antibody diluted 1:2000
in 2%milk in TTBS for 1 h at RT. Membranes were then washed
three times with TBS. Immunoreactive protein bands were visu-
alized by the ECL Plus Western Blotting Detection System (GE
Healthcare) according to the manufacturer’s instructions.
Statistical Analyses
All the statistical analyses were performed using GraphPad Prism
3.0 (GraphPad Software). Significance of differences was assessed
by One Way ANOVA followed by Dunnett post-hoc test when
drugs-treated cultures were compared to the corresponding con-
trol cultures treated with vehicle, or by Tuckey post-hoc test
for intergroups comparisons. Significance threshold was set at
p < 0.05.
Results
Neuronal Cultures From Cortex and Striatum of
Mouse Brain
As expected from previous data on rat primary cultures
(Speranza et al., 2013), the phenotype of cells obtained from the
CTX and STR of mouse brains at E15 showed that almost 95%
of STR and CTX cells in culture were neurons, as judged by co-
localization of Tuj1 antibodies with the nuclear DAPI staining. In
addition, about 90% of striatal and cortical neurons were positive
to 5-HT7R (Figure 1A).
To evaluate the expression levels of the 5-HT7R in our cul-
tures, we first performed real time quantitative RT-PCR analyses.
Although the 5-HT7R mRNAs were slightly higher in the STR
than in the CTX, the difference was not statistically significant
(Figure 1B). Accordingly, Western blot analyses showed that the
abundance of the 5-HT7R protein normalized to that of β-actin,
was similar in both areas (Figure 1C).
After 3 days in culture, cells were stimulated with the selective
5-HT7R agonist (LP-211; Hedlund et al., 2010) and stained with
the Tuj1 antibodies for morphometrical analysis at various time
points, in order to measure the neurite elongation. Figure 2A
shows representative images of CTRL and LP-211 treated neu-
rons. In line with our previous data (Speranza et al., 2013), we
observed that the exposure of neuronal cultures to 100 nM LP-
211 caused a significant increase in the length of neurites after
2 h of stimulation in comparison to the control cultures treated
with vehicle for the same time length (CTRL, Figure 2B). This
effect was specifically due to 5-HT7R, as co-treatment of the
cells with LP-211 and the 5-HT7R selective antagonist SB-269970
completely abolished the neurite elongation, while addition of the
antagonist alone for 2 h had no effect (data not shown).
Signal Transduction Pathways Involved in
5-HT7R-Dependent Neurite Elongation
mTOR Signaling Pathway
Since in neuronal cells mTOR signaling plays a pivotal role in
dendritic and axonal growth, we chose to investigate its involve-
ment in neurite elongation stimulated by 5-HT7R. To this aim,
we used rapamycin, a drug that interacts with and inhibits the
mTOR kinase activity, and torin 1, a specific ATP-competitive
mTOR inhibitor. As shown in Figure 2B, in cortical cultures the
LP-211-induced enhancement of neurite elongation was com-
pletely abrogated by the co-treatment with 20 nM rapamycin
or 250 nM torin 1. Treatment with rapamycin or torin 1 alone
did not affect neurite length. Comparable results were obtained
using striatal neurons (data not shown). To further confirm the
involvement of the mTOR signaling following agonist stimula-
tion of the 5-HT7R, we investigated the phosphorylation level
of the p70 S6 kinase (p70S6K), a direct mTOR downstream sub-
strate (Burnett et al., 1998). To assess the proportion of the phos-
phorylated form of p70S6K, we performedWestern blot analyses
using two different antibodies specific for total p70S6K protein
(including both phosphorylated and unphosphorylated form)
and for the phosphorylated form of the enzyme. The calculated
ratio of phospho-p70S6K/ p70S6K was thus used as an index of
the mTOR kinase activity. As shown in Figure 3A, we found that
treatment of neuronal cultures with LP-211 strongly enhanced
p70S6K phosphorylation. Treatment with torin 1, alone or in
combination with LP-211, completely blocked this phosphoryla-
tion, confirming that it is due to mTOR kinase activity.
mTOR interacts with several proteins to form two distinct
complexes namedmTOR complex1 (mTORC1) and mTOR com-
plex2 (mTORC2), with different upstream and downstream effec-
tors. mTORC2, but not mTORC1, directly activates the protein
kinase Akt by phosphorylating its hydrophobic motif (Ser473;
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FIGURE 1 | Characterization of striatal and cortical primary
cultures. (A) Photomicrographs of the cells in striatal and cortical
cultures immunostained with specific antibodies against neuronal
marker Tuj1 (red), and 5-HT7R (green), as indicated in each panel.
Cell bodies were counterstained with the nuclear marker DAPI (blue).
(B) Expression levels of 5-HT7R mRNAs, determined by real time
RT-PCR, in neuronal cultures. The bars represent the 5-HT7R mRNA
levels normalized with those of the housekeeping gene HPRT (means
± SEM; n = 3). (C) Quantitation of 5-HT7R protein in neuronal
cultures. The bars represent the densitometric values of 5-HT7R
Western blot signals normalized with those of β-actin signals in the
same samples (mean ± SEM; n = 3). STR: cultures from the striatal
complex of E15 mouse embryos; CTX: cultures from the cortex of
E15 mouse embryos.
Sarbassov et al., 2005). Therefore, to discriminate between
mTORC1 and mTORC2, we analyzed the phosphorylation levels
of Akt at Ser473 by Western blot analyses, using two antibod-
ies specific for total Akt protein (including both phosphorylated
and unphosphorylated form) and for the phosphorylated form of
the enzyme. The phosphorylated Akt isoform, normalized to the
total Akt protein did not change significantly in LP-211 stimu-
lated neurons compared to CTRL, suggesting lack of mTORC2
involvement (Figure 3B).
Altogether these results indicate that 5-HT7R-stimulation by
LP-211 activates mainly mTORC1 signaling.
Cdc42 Signaling Pathway
Cdc42 is a protein belonging to the Rho/Rac/Cdc42 GTPase sub-
family, that plays a key role in regulating axonal and dendrite
morphogenesis (Luo, 2000; Auer et al., 2011). To study its pos-
sible implication in neurite outgrowth induced by 5-HT7R stim-
ulation, we treated mouse striatal and cortical cultures with ZCL
278, a selective inhibitor of Cdc42. As shown in Figure 4, the LP-
211-induced enhancement of neurite elongation in cultures from
both brain regions was completely abolished by the co-treatment
with 50µM ZLC. It is noteworthy that the treatment with ZCL
alone significantly reduced the neurite length in comparison to
CTRL of about 10% in striatal cultures and about 20% in corti-
cal cultures. Taken together these data indicate that the Cdc42
signal transduction pathway is involved not only in the enhanced
neurite outgrowth induced by LP-211 stimulation of 5-HT7R, but
also in time-dependent neurite elongation occurring in basal con-
dition. Thus, this pathway may represent the general signaling
system leading to neurite elongation.
ERK and Cdk5 Signaling Pathways
ERK signaling pathway is implicated in neurite outgrowth
(Colucci-D’Amato et al., 2003; Jessberger et al., 2009). In addi-
tion, we previously demonstrated that in striatal and cortical rat
neuronal cultures, the enhanced neurite elongation induced by
5-HT7R stimulation requires ERK phosphorylation and Cdk5
activation (Speranza et al., 2013). Thus, we analyzed the effect
of LP-211 on ERK activation also in the striatal mouse neuronal
cultures. In line with data on neurite elongation, when neuronal
cultures were treated with LP-211 for 2 h, the extent of ERK phos-
phorylation was significantly increased when compared to CTRL,
and this effect was blocked by the co-treatment with 5-HT7R
antagonist (SB-269970; Supplementary Figure 1A). These results
show that the stimulation of 5-HT7R is responsible for the ERK
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FIGURE 2 | mTOR signaling pathway is required for neurite
elongation induced by 5-HT7R stimulation. Cortical neurons were
treated for 2 h with the 5-HT7R selective agonist LP-211 (LP, 100 nM), or
the mTOR inhibitors rapamycin (RAPA, 20 nM), or torin 1 (TR1, 250 nM)
with or without LP. (A) Representative Tuj1 immunostaining of neuronal
cultures (magnification 20x). The images in the lower row are the same of
the upper row with the addition of the dashed yellow lines manually
drawn by the operator from the soma (yellow circle) to the end of the
primary neurite in order to measure neurite length. (B) The graph shows
the neurite length expressed as percentage of values measured in the
corresponding vehicle-treated cultures (CTRL, set to 100%). The bars
represent means ± SEM from randomly selected fields for each cell
culture condition (n = 9). Asterisk (*): value significantly different from
CTRL by One Way ANOVA followed by Dunnett post-hoc test (p < 0.05).
activation. As expected, the ERK phosphorylation induced by LP-
211 was abolished by the treatment with ERK inhibitor, U0126,
for 2 h, andU0126 alone also significantly reduced ERK phospho-
rylation in unstimulated cells (Supplementary Figure 1A). Inter-
estingly, inhibition of ERK phosphorylation byU0126 completely
abrogated the enhancement of neurite outgrowth induced by LP-
211, while treatment with U0126 alone did not affect neurite
elongation (Supplementary Figure 1B).
In line with our previous data (Speranza et al., 2013), we also
confirmed that treatment of mouse striatal cultures with roscovi-
tine (inhibitor of Cyclin-dependent protein kinase 5, Cdk5) com-
pletely abrogated neurite elongation induced by treatment with
LP-211 for 2 h (data not shown).
Activation of 5-HR7 Induces Qualitative and
Quantitative Changes of the Actin Cytoskeleton
To establish the relationship between 5-HT7R activation and
actin cytoskeleton dynamics, we treated mouse striatal cultures
with 100 nM cytochalasin B or 2µM latrunculin A. These agents,
promoting net depolymerization of the actin filaments, nearly
abolished the neurite outgrowth stimulated by LP-211, indicat-
ing that this enhanced elongation required the polymerization
of actin pool (Figure 5). When added to the culture media with-
out LP-211, these two compounds significantly reduced the neu-
rites length in comparison with the vehicle-treated cells (CTRL).
Accordingly, when the striatal neurons were exposed to the
agent promoting actin polymerization (jasplakinolide, 2µM)
the length of their neurites significantly increased (Figure 5).
Interestingly, when neurons were co-treated with jasplakino-
lide and LP-211, the effect was not cumulative and the neu-
rites length was similar to the one obtained with LP-211 alone.
Collectively, these results indicate that the neurite outgrowth
induced by LP-211 depends on modulation of actin cytoskeleton
dynamics.
To further investigate the role of the cytoskeleton in LP-211-
induced neurite elongation, we have studied the effects of LP-211
on mouse striatal and cortical cultures using 2D protein analy-
ses of β-tubulin, β-actin and cofilin. Immunostaining of 2D-gels
of both control striatal and cortical cultures showed a marked
stretching of both β-tubulin and actin spots, attesting a high level
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FIGURE 3 | Stimulation of 5-HT7R activates mTORC1 signaling. Cortical
neurons were treated for 2 h with the 5-HT7R selective agonist LP-211 (LP,
100 nM), or the mTOR inhibitor torin 1 (TR1, 250 nM), alone or in combination.
(A) The bars show the level of p70S6K phosphorylation at Thr389 (means ±
SEM, n = 6), expressed as percentage of values measured in the
corresponding vehicle-treated cultures (CTRL, set to 100%). The level of
p70S6K phosphorylation was measured by Western blot as intensity of
p70S6K phosphorylated at Thr389 (p-p70S6K) normalized with that of total
(phosphorylated and unphosphorylated) p70S6K in the same samples. The
inset displays representative blots probed with antibodies against p-p70S6K
and p70S6K; the molecular weights (kDa) are shown on the right. (B) The bars
show the level of Akt phosphorylation at Ser473 (means± SEM, n = 3),
expressed as percentage of values measured in the corresponding
vehicle-treated cultures (CTRL, set to 100%). The level of Akt phosphorylation
was measured by Western blot as intensity of Akt phosphorylated at Ser473
(p-Akt) normalized with that of total Akt (Akt) in the same samples. The inset
displays representative blots probed with antibodies against p-Akt and Akt;
the molecular weights (kDa) are shown on the right. Asterisk (*): value
significantly different from CTRL by One Way ANOVA followed by Dunnett
post-hoc test (p < 0.05).
of protein heterogeneity in terms of post-translational modifi-
cation. These protein stretches were not substantially affected
upon treatment with LP-211 with the exception of a reduc-
tion of the actin acidic spots, more marked in striatal neurons
(Figures 6A,C). Interestingly, LP-211 treatment was found to
alter the 2D expression profile of cofilin, a regulator of actin fila-
ment assembly/disassembly, in striatal and cortical cells. Indeed,
a shift of the stretch of cofilin spots at 21 kDa toward acidic pH
region was observed following LP-211 treatment.
SDS-PAGE and Western blot analyses using antibodies for
total cofilin and for cofilin phosphorylated at Ser3 (pS3) did not
show significant difference between CTRL and LP-211 treated
striatal or cortical neurons (Figures 6B,D). These results indicate
that the shift of cofilin toward the acidic region observed in 2D-
gels following stimulation of the 5-HT7R cannot be attributed to
its phosphorylation at Ser3.
FIGURE 4 | Cdc42 signaling pathway is required for neurite
elongation induced by 5-HT7R stimulation. (A) Striatal and (B) cortical
neurons were treated for 2 h either with the 5-HT7R selective agonist
LP-211 (LP, 100 nM), or with the selective Cdc42 inhibitor ZCL (50µM), or
with a combination of the two. The graphs show the neurite length
expressed as percentage of values measured in the corresponding
vehicle-treated cultures (CTRL, set to 100%). The bars represent means ±
SEM from randomly selected fields for each cell culture condition (n = 6).
Asterisk (*): values significantly different from CTRL by One Way ANOVA
followed by Dunnett post-hoc test (p < 0.05). Number sign (#): values
significantly different from each other by One Way ANOVA followed by
Tuckey post-hoc test (p < 0.05).
Activation of 5-HT7R Stimulates Axonal
Outgrowth
Although neurite outgrowth is studied in cultured neurons before
the occurrence of neuronal polarization, it is generally considered
the equivalent of axonal extension (Conti et al., 1997). To deter-
mine whether 5-HT7R could indeed modulate axonal growth, we
used microfluidic culture platforms that allow physical separa-
tion between soma and axons of cultured neurons (Park et al.,
2006). Microfluidic chambers have been mostly used with HIPP
neurons for their ability to develop long axons. Therefore, we first
tested the effect of 2 h stimulation with LP-211 on neurite elonga-
tion of E18 mouse HIPP neurons cultured in traditional chamber
slides. These cultures were immunostained with TuJ1 antibod-
ies and counterstained with the nuclear marker DAPI, indicating
that most of cultured cells were neurons (see panels in Figure 7).
Consistent with previous results obtained with other 5-HT7R
agonists (Kvachnina et al., 2005), we observed that the length
of neurites significantly increased in LP-211-treated cultures
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FIGURE 5 | Actin polymerization is required for neurite elongation
induced by 5-HT7R stimulation. Striatal primary cultures were treated for
2 h with the 5-HT7R selective agonist LP-211 (LP, 100 nM). Cells were also
treated with compounds depolymerizing actin filaments, as cytochalasin B
(CYT, 100 nM) or latrunculin A (LATR, 2µM), or promoting actin
polymerization as jasplakinolide (JASP, 2µM), with or without LP. The graph
shows the neurite length expressed as percent values in reference to
vehicle-treated cultures (CTRL, set to 100%). The bars represent means ±
SEM from randomly selected fields for each cell culture condition (n = 9).
Asterisk (*): values significantly different from CTRL by One Way ANOVA
followed by Dunnett post-hoc test (p < 0.05). Number sign (#): values
significantly different from each other by One Way ANOVA followed by
Tuckey post-hoc test (p < 0.05).
compared to CTRL; the co-treatment of neurons with LP-211
and SB-269970 completely abolished neurite elongation, while
addition of the antagonist alone did not affect neurite outgrowth
(Figure 7).
Then, we cultured HIPP neurons in microfluidic chambers
(Park et al., 2006), implementing culture medium with 100 nM
of the agonist. Neurons were plated on one side of the cul-
ture chamber (soma compartment) and axons, but not dendrites,
grew into the other compartment, passing through interconnect-
ing micro-channels (450µm long) (Figure 8A). We first verified
whether in our system the only fibers crossing the channels were
axons, by co-immunolabeling hippocampal neurons with Tuj1
(neuronal marker) and either anti-Tau (axon specific marker)
or anti-Map2 (dendrite specific marker). As expected, the anti-
Tau antibody labeled axons in both compartments, while den-
dritic labeling withMap2 was confined to the soma compartment
(Figure 8B). Therefore, we plated HIPP neurons in the presence
of either LP-211 or vehicle (CTRL), added to both compart-
ments. Cultures were maintained for 6 days and axons reaching
the appropriate compartment were counted daily, from 1DIV
to 6DIV. In LP-211-treated cultures we observed a significant
increase in the number of axons crossing the channels by 3 to
5DIV, clearly indicating that stimulation of the 5-HT7R promotes
axonal growth, at least at early stages (Figure 8C). This differ-
ence disappeared at 6DIV, suggesting receptor desensitization,
although we have also considered the hypothesis that the num-
ber of axons would eventually reach a plateau, since the num-
ber of channels to cross is limited. Figure 8D shows two typical
cultures, grown in the presence of either DMSO or LP-211, indi-
cating that, before plateau is reached, the number of axons reach-
ing the side compartment is higher in the presence of 5-HT7R
agonist.
Discussion
Neurotransmitters have a well-established role for neuronal com-
munication in the adult CNS, but many of them, including
serotonin, have been shown to act as signaling molecules dur-
ing neuronal development regulating neurite outgrowth, den-
dritic spines shape and number, target selection and synapse
formation (Van Kesteren and Spencer, 2003; Lesch and Waider,
2012).
Accordingly, a role for 5-HT7R in the regulation of neurite
outgrowth was demonstrated on mouse hippocampal neurons
in vitro (Kvachnina et al., 2005), and more recently on rat stri-
atal and cortical cultures (Leo et al., 2009; Speranza et al., 2013).
In line with these findings, in this paper we demonstrate that the
neurite outgrowth observed in cultured embryonic neurons of
mouse striatum, cortex and hippocampus is strongly stimulated
by LP-211, a newly discovered highly selective 5-HT7R agonist
(Hedlund et al., 2010). We show that this process requires the
activation of the serine/threonine kinase mTOR, and the Rho
GTPase Cdc42, in addition to Cdk5 activation and ERK phos-
phorylation, corroborating and extending our previous findings
on rat neuronal cultures (Speranza et al., 2013).
In neuronal cells, mTOR is implicated in multiple pro-
cesses, including transcription, ubiquitin-dependent proteoly-
sis, and microtubule and actin dynamics, all of which are
crucial for neuronal development and long-term modification
of synaptic strength (Jaworski and Sheng, 2006). Moreover,
mTOR is recruited following activation of various G protein-
coupled receptors and thereby plays a role in synaptic plasticity
through formation and maturation of new synapses (Hoeffer and
Klann, 2010; Meffre et al., 2012). The two distinct multiprotein
complexes formed by mTOR with different accessory proteins,
mTORC1 and mTORC2, are differently sensitive to rapamycin
(Takei and Nawa, 2014). Recent efforts have led to the devel-
opment of torin 1, an ATP-competitive mTOR inhibitor block-
ing both mTORC1 and mTORC2 complex activity (Liu et al.,
2010). Our results show for the first time that the neurite elon-
gation induced by agonist stimulation of 5-HT7R is dependent
on mTOR, as the outgrowth is completely inhibited by both
rapamycin and torin 1. Accordingly, phosphorylation of the
p70SK, one of the well known targets of mTOR (Laplante and
Sabatini, 2012), was strongly increased by treatment of neuronal
cultures with LP-211, and completely abolished by co-treatment
with torin 1. These results are in agreement with the recent find-
ings that the in vivo treatment with LP-211 stimulates mTOR
signaling in the mouse brain (De Filippis et al., 2014) and high-
light the key role of this pathway in mediating the effects induced
by 5-HT7R stimulation in the CNS. On the other hand, our anal-
yses indicate that phosphorylation of Akt, one of the well known
targets of mTORC2 (Takei and Nawa, 2014), was not affected by
the treatment of neuronal cultures with LP-211, suggesting that
the intracellular cascade stimulated by 5-HT7R involves mainly
mTORC1.
Another piece of the puzzle was provided by the recent studies
in which Rho GTPases have been identified as key regulators of
actin cytoskeleton rearrangement leading to axonal and dendritic
growth. Thus, it has been suggested that Rho GTPases may act
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FIGURE 6 | Effect of LP-211 on expression levels of several
cytoskeletal proteins in neuronal primary cultures. 2D immunoblot
analyses, using antibodies against β-tubulin, actin or cofilin, were performed
on (A) striatal cells or (C) cortical cells treated with vehicle (CTRL) or with the
5-HT7R selective agonist LP-211. The graphs on the right show the level of
cofilin phosphorylation on Ser 3 (pS3-cofilin) in striatal (B) and cortical (D)
neurons treated for 2 h with LP-211 (LP, 100 nM). The intensity of pS3-cofilin
was normalized with that of total cofilin (means ± SEM; n = 3) and was
expressed as percentage of values measured in the corresponding
vehicle-treated cultures (CTRL, set to 100%). The insets display
representative SDS-PAGE blots probed with antibodies against pS3-cofilin
and cofilin. The molecular weights (kDa) are indicated on the right.
as a molecular switches integrating signals from the extracellular
environment (Auer et al., 2011; Li et al., 2014). As a member
of Rho GTPases protein family, Cdc42 is involved in neuronal
morphogenesis including axon growth and guidance, dendritic
spine plasticity and synapse formation (Luo, 2000). This GTPase
is required for filopodia formation and for the concomitant acti-
vation of the actin regulator cofilin in growth cones (Garvalov
et al., 2007). In accordance with these observations, our results
clearly indicate that Cdc42 indeed plays a crucial role in the LP-
211-dependent enhancement of neurite outgrowth. Thus, this
Rho GTPase may be considered a key molecule in the signaling
pathways coupling activation of 5-HT7R with the cytoskeleton
reorganization.
As aforementioned, we previously demonstrated that ERK
and Cdk5 are also activated during the LP-211-induced enhance-
ment of neurite outgrowth (Speranza et al., 2013), which has
been corroborated here in cultured neurons obtained from var-
ious regions of the mouse brain (Supplementary Figure 1). The
involvement of ERK and Cdk5 are consistent with the well-
known role of these pathways as critical signal transmission hubs
positioned between a range of cell surface receptors and various
cytoskeletal systems regulating neuronal morphology (Colucci-
D’Amato et al., 2003; Jessberger et al., 2009). Thus, our new
experimental evidence showing that mTOR and Cdc42 are also
involved in the signaling pathways activated by 5-HT7R suggest
that this newly found member of the 5-HT receptor family uses
a variety of molecular tools to exert its effect on neurite out-
growth during development. Accordingly the link between some
of these signal trasduction pathways has been demonstrated in
several different experimental systems (Kvachnina et al., 2005;
He et al., 2013). A plausible hierarchical order for these down-
stream 5-HT7R signaling components would envisage recruit-
ment of Cdk5 and Cdc42, in analogy to recent findings by Duhr
et al. (2014). These authors have shown that both these signal-
ing pathways are involved in the 5-HT6R neurite elongation, and
that Cdk5 constitutively interacts and phosphorylates the recep-
tor. This cooperation might occur also for 5-HT7R, and Cdk5
would in turn activate ERK signaling, as observed in rat primary
cultures (Speranza et al., 2013). ERK pathway might then acti-
vate mTORC1, as reviewed by Laplante and Sabatini (2012). In
addition, Cdc42 could be a downstream Cdk5 mediator of neu-
rite growth, operating in parallel to ERK pathway (Cheung et al.,
2007).
The protruding force responsible for the extension of neuronal
processes relies on the modulation of cytoskeleton dynamics, in
particular on the regulation of microtubules and microfilaments
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FIGURE 7 | Stimulation of 5-HT7R enhances neurite outgrowth in
hippocampal primary cultures. Hippocampal cells were treated for 2 h
with the 5-HT7R selective agonist LP-211 (LP, 100 nM), alone or in
combination with the selective 5-HT7R antagonist SB269970 (SB, 100 nM).
Neurite length was measured on cells stained with anti-Tuj1 antibody, and
expressed as percentage of values measured in the corresponding
vehicle-treated cultures (CTRL, set to 100%). The bars represent means ±
SEM from randomly selected fields for each cell culture conditions (n = 10).
Asterisk (*): values significantly different from CTRL by One Way ANOVA
followed by Dunnett post-hoc test (p < 0.05). The panels below each bar
display representative images of hippocampal neurons immunostained with
the neuronal marker Tuj1 (red) and counterstained with the nuclear marker
DAPI (blue; magnification 20x).
polymerization (Schaefer et al., 2008). Accordingly, our data
indicate that the neurite outgrowth induced by 5-HT7R stimu-
lation depends on actin filaments. Indeed the stimulating effect
of LP-211 on neurite outgrowth was blocked by the addition of
actin-binding drugs that promote net depolymerization of actin
filaments, either by sequestering the free actin monomer pool
(latrunculin) or by capping the fast-growing barbed ends of actin
filaments (cytochalasin). On the other hand, the treatment with
jasplakinolide, which stabilizes polymerization of actin filaments,
increased the neurite length in the absence of LP-211. However,
the co-treatment with jasplakinolide and LP-211 did not promote
additional neurite outgrowth compared to the treatment with
the agonist alone, suggesting that 5-HT7R activation may have
stimulated the outgrowing mechanism at its maximum level. It
is important to consider that the modulation of actin dynamics
is an extremely complex process, as revealed by either stimula-
tory or inhibitory effects of actin polymerization drugs on axonal
or dendritic growth (Bradke and Dotti, 1999; Gallo et al., 2002;
Jones et al., 2004). These apparently divergent results may be
attributed to the different stages of development/differentiation
of neuronal processes, as well as the various experimental con-
ditions (i.e., drug treatment, neuronal cultures) used by differ-
ent investigators. Altogether, our data are consistent with the
knowledge that the cellular mechanisms regulating neurite out-
growth are deeply influenced by actin dynamics (Schaefer et al.,
2008).
Many extracellular signaling molecules enhancing neurite
outgrowth exert profound effects on the organization of the
actin cytoskeleton, mainly acting on actin-binding proteins,
such as cofilin. The regulation of cofilin phosphorylation is a
key convergence point of multiple cell signaling networks that
link extracellular stimuli to actin cytoskeletal dynamics (Huang
et al., 2006, 2013; Mizuno, 2013). It has been suggested that
cofilin activity, modulated by a proper balance of its phospho-
rylation level, may act as a regulator for neurite extension in
specific subcellular regions of the neuron (Endo et al., 2007;
Figge et al., 2012). Interestingly, recent data indicate that stim-
ulation of 5-HT7R is able to reverse the abnormal activation
of cofilin in a mouse model of Rett syndrome (De Filippis
et al., 2014). Here, following 5-HT7R agonist stimulation of
both striatal and cortical neurons, we didn’t detect significant
changes of cofilin phosphorylation at Ser3 by Western blot anal-
yses. On the other hand, the 2D gel profiles of cofilin protein
from LP-211 treated cultures undergo significant changes com-
pared to control cultures, showing a shift toward acidic pH
of multiple spots without changes in molecular mass. These
changes may be ascribed to phosphorylation on residues differ-
ent from Ser3, or to other post-translational modifications. The
detailed analyses of these modifications will be object of further
investigation.
Many experiments using cultured embryonic hippocampal
neurons have revealed that, as they develop, neurons initially gen-
erate several equivalent neurites, but then begin to polarize so
that one neurite becomes an axon while the remaining neurites
become dendrites (Dotti et al., 1988).
Interestingly, here we demonstrate for the first time that
stimulation of the 5-HT7R enhances axonal elongation in cul-
tured hippocampal neurons. These data, coupled with previous
results indicating involvement of 5-HT7R in potentiating for-
mation of dendritic spines in hippocampal neurons, strongly
support the emerging role of 5-HT7R in shaping brain net-
works during development by modulating neuronal cytoarchi-
tecture and connectivity (Kobe et al., 2012; Volpicelli et al.,
2014).
In addition, the stimulating effect of 5-HT7R on axonal
elongation open a new perspective suggesting the involvement
of 5-HT7R in axonal pathfinding and regeneration, presum-
ably through the activation of mTOR signaling and cofilin.
Indeed, recent data indicate that mTOR pathways and cofilin
activation play a key role in the mechanism underlying the
ability of axon to regenerate (Stern et al., 2013; Lu et al.,
2014).
Interestingly, the successful rescue of functional and behav-
ioral deficits observed in animal models of Fragile X syndrome
and Rett syndrome (Costa et al., 2012; De Filippis et al., 2014),
following stimulation of the 5-HT7R, identify this receptor as a
potential target for innovative pharmacological treatment of sev-
eral neurodevelopmental diseases associated with abnormal CNS
connectivity.
In summary, our results highlight the role of 5-HT7R and
its signal transduction pathways in shaping neuronal morphol-
ogy in embryonic forebrain neurons in culture, suggesting its
involvement in the correct establishment of neuronal wiring dur-
ing critical periods of CNS development. Similar mechanisms
could operate also in the mature brain to modulate plasticity of
neural circuits.
Frontiers in Behavioral Neuroscience | www.frontiersin.org 11 March 2015 | Volume 9 | Article 62
Speranza et al. 5-HT7R, mTOR and neurite elongation
FIGURE 8 | Stimulation of 5-HT7R enhances axonal outgrowth in
cultured hippocampal neurons. (A) Schematic representation of
microfluidic chambers. (B) Co-immunolabeling of neurons cultured in
microfluidic chambers with the neuronal marker Tuj1 (green) and either
the axonal marker Tau (top row, red) or the dendritic marker Map2
(bottom row, red). Dendritic immunolabeling is confined in the soma
compartment and only axons cross the micro-channels to reach the
other compartment. (C) The number of axons crossing the
micro-channels is significantly higher in LP-211 treated cultures (LP,
red line), respect to control (DMSO, blue line), after 3, 4, and 5DIV.
Asterisk (*): values significantly different from DMSO by One Way
ANOVA followed by Dunnett post-hoc test (p < 0.05). (D)
Representative hippocampal cultures grown in the presence of DMSO
or LP and immunolabeled with the Tuj1 antibody (green).
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